• Lanabecestat (AZD3293): Precision BACE1 Inhibition for Alzhe

  2026-04-21

  Lanabecestat (AZD3293) empowers Alzheimer’s disease research with potent, blood-brain barrier-penetrant BACE1 inhibition, enabling synaptic-sparing amyloid-beta modulation. This guide translates recent peer-reviewed breakthroughs and practical workflows into actionable, reproducible protocols for both in vitro and in vivo studies.

• Lanabecestat (AZD3293): Protocols for Synaptic-Safe BACE1 In

  2026-04-20

  Lanabecestat (AZD3293) empowers Alzheimer’s disease research with high-affinity, blood-brain barrier-penetrant BACE1 inhibition that preserves synaptic function at optimized dosages. This guide unpacks workflow-driven protocols, troubleshooting strategies, and a pivotal reference study to help researchers achieve reproducible, synaptic-sparing amyloid-beta reduction.

• Atropo-Enantioselective Suzuki Coupling Enables Chiral Biary

  2026-04-20

  This study describes a catalytic asymmetric Suzuki cross-coupling for the synthesis of axially chiral bridged biaryls, specifically targeting a structural analogue of (-)-rhazinilam with potent antimitotic properties. The work establishes a practical methodology for generating biologically relevant chiral biaryls, providing a foundation for future research in chiral ligand and natural product synthesis.

• IWP-L6: Precision Porcupine Inhibitor for Wnt Pathway Modula

  2026-04-19

  IWP-L6 stands out as a sub-nanomolar Porcupine inhibitor, enabling highly specific and reproducible Wnt pathway suppression in diverse experimental systems. This guide translates cutting-edge metabolic findings and validated protocols into actionable strategies for developmental, metabolic, and regenerative research.

• Tacrine-Based Hybrids: Advances in Multi-Target Strategies f

  2026-04-18

  This review examines the evolution of tacrine-based hybrids as multi-target agents for Alzheimer's disease, highlighting their design to address multiple pathological hallmarks beyond cholinesterase inhibition. The paper contextualizes tacrine's scientific legacy and explores how structural modifications may overcome prior limitations, such as hepatotoxicity, offering new avenues for neurodegenerative disease research.

• Kanamycin Sulfate: Water-Soluble Antibiotic for Research Pre

  2026-04-17

  Kanamycin Sulfate is a high-purity, water-soluble antibiotic widely used in microbiology and antibiotic resistance research. Its mechanism involves selective inhibition of bacterial protein synthesis by targeting the 30S ribosomal subunit. APExBIO's Kanamycin Sulfate (SKU A2516) offers validated purity and performance, supporting reproducible experimental outcomes.

• Cy5-UTP for RNA Labeling: Protocols, Applications & Troubles

  2026-04-16

  Cy5-UTP (Cyanine 5-UTP) enables robust, direct fluorescent RNA probe synthesis for advanced applications like FISH and dual-color arrays. This guide details stepwise workflows, expert troubleshooting, and data-driven enhancements to maximize labeling sensitivity and reproducibility.

• Ceftazidime: Third-Generation Cephalosporin in Gram-Negative

  2026-04-15

  Ceftazidime enables robust, reproducible workflows for Gram-negative bacterial infection research, with proven β-lactamase resistance that enhances assay reliability. Learn how to optimize its use for experimental precision and troubleshoot common pitfalls, leveraging new insights from resistance transmission dynamics.

• Starvation-Induced ER-Ca2+-Calpain Axis Drives PCD in Bombyx

  2026-04-14

  This study dissects how starvation triggers a regulated switch from autophagy to apoptosis in the Bombyx mori fat body, mediated by ER Ca2+ signaling and calpain activation. The work clarifies the molecular logic underlying programmed cell death transitions under nutritional stress and demonstrates the pivotal role of IP3R-mediated calcium mobilization.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Use &

  2026-04-13

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) is formulated to prevent unwanted proteolysis during protein extraction and sample handling, particularly when divalent cations must be preserved for downstream assays. It should be used in workflows where EDTA would interfere, such as phosphorylation analysis or enzyme assays, but is not suitable for applications that require metalloprotease inhibition via chelation.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-04-13

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with diverse stromal cell subpopulations, enabling a physiologically relevant platform for drug screening and resistance studies. The model offers improved mimicry of tumor heterogeneity, supporting more predictive and personalized preclinical research.

• Sunitinib as a Multi-Targeted RTK Inhibitor: Protocols & Tro

  2026-04-12

  Leverage Sunitinib’s multi-targeted receptor tyrosine kinase inhibition to dissect angiogenesis, apoptosis, and cell cycle arrest in advanced cancer models. This guide translates cutting-edge glioma research into actionable workflows, offering experimental enhancements and troubleshooting strategies for reliable, reproducible results with APExBIO’s Sunitinib.

• Partial β-Secretase Inhibition Reduces Amyloid β Without Syn

  2026-04-12

  Satir et al. (2020) demonstrate that partial inhibition of β-secretase can lower amyloid β production by up to 50% without compromising synaptic transmission in cultured neurons. This finding refines therapeutic strategies for Alzheimer's disease, indicating that moderate enzyme inhibition may avoid synaptic side effects seen with higher doses.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Usage

  2026-04-11

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) is designed to prevent protein degradation during extraction and sample preparation, especially in workflows sensitive to divalent cations. It is not appropriate for protocols requiring metalloprotease inhibition via EDTA, or where DMSO is incompatible with downstream steps.

• Puromycin Dihydrochloride: Optimized Workflows for Selection

  2026-04-11

  Puromycin dihydrochloride, an aminonucleoside antibiotic, empowers precise cell line selection and advanced translation process analysis. This article delivers actionable protocols, troubleshooting insights, and a practical translation of new regulatory findings from breast cancer research into robust laboratory workflows.

16133 records 1/1076 page Next 12345 下5页 Last page